Gene Therapy Study in Severe Haemophilia A Patients (270-201)

Clinical trial NCT02576795 · COMPLETED

Trial details

NCT number: NCT02576795
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Severe Haemophilia A

Start date: 2015-09-28
Primary completion: 2024-02-14
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.